Capital International Investors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.13B | Buy |
14,418,993
+2,726,228
| +23% | +$605M | 0.74% | 32 |
|
|
2025
Q4 | $2.67B | Buy |
11,692,765
+989,233
| +9% | +$225M | 0.42% | 56 |
|
|
2025
Q3 | $2.48B | Sell |
10,703,532
-2,947,890
| -22% | -$600M | 0.4% | 58 |
|
|
2025
Q2 | $2.53B | Sell |
13,651,422
-6,885,308
| -34% | -$1.28B | 0.44% | 57 |
|
|
2025
Q1 | $4.3B | Sell |
20,536,730
-7,996,758
| -28% | -$1.55B | 0.85% | 26 |
|
|
2024
Q4 | $5.07B | Sell |
28,533,488
-8,254,356
| -22% | -$1.52B | 0.95% | 24 |
|
|
2024
Q3 | $7.26B | Sell |
36,787,844
-1,814,340
| -5% | -$339M | 1.39% | 14 |
|
|
2024
Q2 | $6.62B | Sell |
38,602,184
-9,496,600
| -20% | -$1.57B | 1.36% | 15 |
|
|
2024
Q1 | $8.76B | Buy |
48,098,784
+3,110,601
| +7% | +$536M | 1.77% | 8 |
|
|
2023
Q4 | $6.97B | Buy |
44,988,183
+2,542,463
| +6% | +$371M | 1.56% | 9 |
|
|
2023
Q3 | $6.33B | Sell |
42,445,720
-707,021
| -2% | -$104M | 1.61% | 7 |
|
|
2023
Q2 | $5.81B | Buy |
43,152,741
+404,379
| +0.9% | +$59.3M | 1.4% | 13 |
|
|
2023
Q1 | $6.81B | Sell |
42,748,362
-4,350,245
| -9% | -$665M | 1.75% | 8 |
|
|
2022
Q4 | $7.61B | Buy |
47,098,607
+1,271,349
| +3% | +$195M | 2.04% | 5 |
|
|
2022
Q3 | $6.15B | Buy |
45,827,258
+2,672,137
| +6% | +$383M | 1.79% | 8 |
|
|
2022
Q2 | $6.61B | Buy |
43,155,121
+12,657,354
| +42% | +$1.93B | 1.8% | 9 |
|
|
2022
Q1 | $4.94B | Buy |
30,497,767
+18,882,699
| +163% | +$2.74B | 1.13% | 14 |
|
|
2021
Q4 | $1.57B | Buy |
11,615,068
+1,913,451
| +20% | +$226M | 0.33% | 85 |
|
|
2021
Q3 | $1.05B | Buy |
9,701,617
+2,934
| +0% | +$335K | 0.24% | 106 |
|
|
2021
Q2 | $1.09B | Sell |
9,698,683
-1,341
| -0% | -$151K | 0.25% | 100 |
|
|
2021
Q1 | $1.05B | Buy |
9,700,024
+1,828,403
| +23% | +$196M | 0.27% | 101 |
|
|
2020
Q4 | $843M | Sell |
7,871,621
-2,124,479
| -21% | -$204M | 0.23% | 117 |
|
|
2020
Q3 | $876M | Sell |
9,996,100
-1,493,350
| -13% | -$141M | 0.27% | 98 |
|
|
2020
Q2 | $1.13B | Buy |
11,489,450
+3,516,004
| +44% | +$310M | 0.37% | 67 |
|
|
2020
Q1 | $607M | Sell |
7,973,446
-2,909,152
| -27% | -$248M | 0.25% | 99 |
|
|
2019
Q4 | $964M | Sell |
10,882,598
-1,074,055
| -9% | -$89.2M | 0.33% | 92 |
|
|
2019
Q3 | $905M | Sell |
11,956,653
-6,663,544
| -36% | -$457M | 0.35% | 85 |
|
|
2019
Q2 | $1.35B | Sell |
18,620,197
-6,038,670
| -24% | -$475M | 0.54% | 48 |
|
|
2019
Q1 | $1.99B | Sell |
24,658,867
-4,961,746
| -17% | -$406M | 0.85% | 32 |
|
|
2018
Q4 | $2.73B | Buy |
29,620,613
+2,025,965
| +7% | +$178M | 1.36% | 15 |
|
|
2018
Q3 | $2.61B | Buy |
27,594,648
+20,063,435
| +266% | +$1.9B | 1.2% | 18 |
|
|
2018
Q2 | $698M | Buy |
7,531,213
+185
| +0% | +$18.1K | 0.79% | 46 |
|
|
2018
Q1 | $713M | Sell |
7,531,028
-852,200
| -10% | -$93.6M | 0.82% | 40 |
|
|
2017
Q4 | $811M | Buy |
8,383,228
+528,299
| +7% | +$49.8M | 0.92% | 31 |
|
|
2017
Q3 | $698M | Buy |
7,854,929
+4,550,954
| +138% | +$346M | 0.84% | 33 |
|
|
2017
Q2 | $240M | Hold |
3,303,975
| – | – | 0.32% | 100 |
|
|
2017
Q1 | $215M | Hold |
3,303,975
| – | – | 0.29% | 104 |
|
|
2016
Q4 | $207M | Sell |
3,303,975
-2,202,801
| -40% | -$134M | 0.3% | 106 |
|
|
2016
Q3 | $347M | Hold |
5,506,776
| – | – | 0.5% | 60 |
|
|
2016
Q2 | $341M | Buy |
5,506,776
+267,700
| +5% | +$16.3M | 0.5% | 56 |
|
|
2016
Q1 | $299M | Sell |
5,239,076
-293,520
| -5% | -$16.4M | 0.46% | 70 |
|
|
2015
Q4 | $328M | Sell |
5,532,596
-3,233,600
| -37% | -$186M | 0.51% | 64 |
|
|
2015
Q3 | $477M | Sell |
8,766,196
-1,685,000
| -16% | -$110M | 0.87% | 34 |
|
|
2015
Q2 | $702M | Sell |
10,451,196
-3,695,700
| -26% | -$241M | 1.19% | 20 |
|
|
2015
Q1 | $828M | Buy |
14,146,896
+1,634,901
| +13% | +$98.8M | 1.51% | 12 |
|
|
2014
Q4 | $819M | Sell |
12,511,995
-512,700
| -4% | -$32.3M | 1.67% | 9 |
|
|
2014
Q3 | $752M | Sell |
13,024,695
-1,255,330
| -9% | -$69.7M | 1.83% | 9 |
|
|
2014
Q2 | $806M | Buy |
14,280,025
+402,850
| +3% | +$21.1M | 2.08% | 5 |
|
|
2014
Q1 | $713M | Buy |
13,877,175
+3,504,900
| +34% | +$177M | 1.92% | 5 |
|
|
2013
Q4 | $548M | Buy |
10,372,275
+4,245,275
| +69% | +$209M | 1.7% | 8 |
|
|
2013
Q3 | $274M | Buy |
6,127,000
+710,000
| +13% | +$31.5M | 1.17% | 15 |
|
|
2013
Q2 | $224M | Buy |
+5,417,000
| New | +$237M | 1.02% | 22 |
|
Other funds holding ABBV
VCM
VPM
Capital International Investors's ABBV Position: Q1 2026 in Review
Capital International Investors increased its AbbVie (ABBV) stake by 23% in Q1 2026, buying an estimated $605M and bringing the position to 14,418,993 shares worth $3.13B. The position accounts for 0.74% of the portfolio, ranked #32.
Capital International Investors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.76B in Q1 2024. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Capital International Investors held 14,418,993 shares of AbbVie worth $3.13B as of Q1 2026.
- Capital International Investors bought 2,726,228 AbbVie shares in Q1 2026, an estimated $605M.
- AbbVie made up 0.74% of Capital International Investors's portfolio in Q1 2026, its #32 holding.
- Capital International Investors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Capital International Investors's AbbVie position peaked at $8.76B in Q1 2024.
- 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.